Animal Health

Net sales in 2009: EUR 977 million
Headquarters: Monheim (Germany)

The division Animal Health produces and markets more than 100 different animal health and care products worldwide for livestock and companion animals. It is among the most successful suppliers in the field of veterinary medicine, holding fourth place in this market internationally.

Animal Health is particularly well positioned in the steadily growing market for antiparasitic products for companion animals.

The Advantage family of flea control products for dogs and cats, for example, was again one of Bayer HealthCare’s best-selling consumer health products in 2009, generating annual sales of roughly € 336 million.Baycox for the treatment of coccidiosis, a parasitic infectious disease in livestock, enjoyed double-digit sales growth relative to the previous year. Spring 2009 saw the roll-out of the new deworming agent Profender tablets for the control of all relevant intestinal roundworms and tapeworms in dogs.

In the veterinary market, the Baytril antibiotic for the treatment of serious infectious diseases in livestock and companion animals has been setting standards for many years. In addition to products to treat infectious diseases and parasites, Animal Health also markets dietary supplements and care products for companion animals and livestock in various countries.

Animal Health is active in more than 120 countries. Its animal health and care products are produced mainly in Germany and the United States, as well as at additional regional production sites.

The key products include

flea-control medications such as Advantage®, for dogs and cats,
products against ticks,
drugs to treat infectious diseases in livestock and companion animals (Baytril®),
products to control endoparasites in pets (Drontal® and Drontal® Plus)
as well as Baycox®, the innovative product to control coccidia problems in farm animals.